Study of vonoprazan injection for bleeding ulcers
Part of Digestive system clinical trials.
This study tests an investigational medicine given as an injection to help stop bleeding from stomach or duodenal ulcers. It may offer a new option for people who have active bleeding from these ulcers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have signs of upper gastrointestinal bleeding, like vomiting blood, black stools, or positive stool test, within the last 48 hours.
- An endoscopy within the last 24 hours shows a bleeding ulcer in your stomach or duodenum, with a size between 3 and 20 mm.
- The ulcer is actively bleeding or has a visible vessel or clot (Forrest types Ia, Ib, IIa, IIb).
- You have not used certain acid-reducing medicines (like PPIs or H2 blockers) in the last 24 hours before screening.
- You do not have severe bleeding, shock, or need for emergency surgery or embolization.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
This trial compares two acid-reducing medicines—Tegoprazan and Lansoprazole—to see which works better for stopping bleeding from a peptic ulcer. If you have a confirmed upper GI bleed from an ulcer, this study may help find the best treatment for you.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This trial tests whether vonoprazan can reduce ulcers caused by a procedure that ties off enlarged veins in the esophagus (variceal band ligation). It is meant for people with liver cirrhosis who are scheduled to receive this treatment.
This study compares two treatments that reduce stomach acid after a bleeding ulcer has been repaired with an endoscope. It aims to find which one is better at preventing the ulcer from bleeding again.
This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.
Hear when a new Peptic Ulcer Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.